← Open Payments lookup

GAYLA CRAGG: Open Payments

NPI 1730728098 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$622 in 7 payments from 6 companies in 2025. Trend: 2023 $84 · 2024 $0 · 2025 $622

Food & beverage: $622
CompanyPaymentsAmount
Alkermes, Inc.2$187
Xeris Pharmaceuticals, Inc.1$122
Janssen Pharmaceuticals, Inc1$117
Teva Pharmaceuticals USA, Inc.1$100
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$62
E.R. Squibb & Sons, L.L.C.1$35

Products named: RECORLEV, SPRAVATO, ARISTADA, AUSTEDO XR, LYBALVI, CAPLYTA, COBENFY.

Industry payments across DE — which companies pay providers there.